Advertisement

Immunopathology of Herpes Simplex Virus Infections

  • M. Z. Doymaz
  • B. T. Rouse
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 179)

Abstract

The great majority of accounts of immune mechanisms in virus infections have dealt with protective aspects, but it is evident that immune reactions against infected cells or viral antigens may cause tissue damage. Indeed, it is likely that, during clearance of most if not all viruses, an inflammatory reaction ensues after a T cell response is generated (MIMS 1983). It is perhaps a matter of semantics as to whether or not this should be described as immunopathology (IP). For the purpose of this review, IP will be considered as a chronic inflammatory reaction mediated primarily by the immune system that results in tissue damage or a change in immune function which is initiated and perhaps perpetuated by virus infections. Such situations result more commonly following infections with noncytopathic viruses which persist in an expressed form in the body (Sissons and Borysiewicz 1985). Although herpes simplex virus (HSV) is persistent, clearly it is not usually expressed, and productive infections are highly cytopathic. Consequently, HSV is unlikely to participate in many immunopathological situations. Before discussing these, our review briefly surveys the state of affairs with other agents which best indicate immunopathological disease mechanisms and which provide clues to understanding those processes that occur in HSV-induced IP.

Keywords

Herpes Simplex Virus Herpes Simplex Virus Infection Herpetic Keratitis Lymphocytic Choriomeningitis Virus Herpes Simplex Keratitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allan JE, Dixon JE, Doherty PC (1987) Nature of inflammatory process in the central nervous system of mice infected with lymphocytic choriomeningitis virus. In: Oldstone MB (ed) Arena-viruses. Biology and immunotherapy. Springer, Berlin Heidelberg New York, pp 131–143 (Current topics in microbiology and immunology, vol 134)Google Scholar
  2. Beazinger J, Hengartner H, Zinkernagel RM (1986) Cloned cytotoxic T cells specific for lymphocytic choriomeningitis virus induce acute disease and primary footpad swelling in infected mice. Med Microbiol Immunol (Berl) 175: 201CrossRefGoogle Scholar
  3. Braakman E, Rottevell FTM, van Bleek G, van Seventer GA, Lucas CJ (1987) Are MHC Class-ll restricted cytotoxic T lymphocytes important. Immunol Today 8: 265–267CrossRefGoogle Scholar
  4. Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MBA (1980) The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol 30: 275–331PubMedCrossRefGoogle Scholar
  5. Ceredig R, Allan JE, Tabi Z, Lynch F, Doherty PC (1989) Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis. J. Exp Med 165:1539–1551CrossRefGoogle Scholar
  6. Clatch RJ, Melvold RW, Miller SD, Lipton HL (1985) Theiler’s murine encephalomyelitis virus (TMEV) induced demyelinating disease in mice is influenced by the H-2 D region. Correlation with TMEV specific delayed type hypersensitivity reactions. J Immunol 135:1408–1414PubMedGoogle Scholar
  7. Clatch RJ, Lipton HL, Miller SD (1986) Characterization of Theiler’s murine encephalomyelitis virus (TMEV) specific delayed type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J Immunol 136: 920–927PubMedGoogle Scholar
  8. Cunningham AL, Nobel JR (1989) Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro. J Clin invest 83: 490–496PubMedCrossRefGoogle Scholar
  9. Daniels CA (1982) Viral and rickettsial infections. In: Gardner A, Klintworth GK (eds) Pathobiology of ocular diseases. A dynamic approach. Dekker, New York, pp 249–266Google Scholar
  10. Dinning WJ (1984) The therapy of uveitis. A review. In: Saari KM (ed) Uveitis updated. Excerpta Medica, New York, pp 477–481Google Scholar
  11. Dixon JE, Allan JE, Doherty PC (1987) The acute inflammatory process in murine lymphocytic choriomeningitis virus is dependent on Ly 2+ immune T cells. Cell Immunol 107: 8–14PubMedCrossRefGoogle Scholar
  12. Doherty PC, Allan JE, Lynch F, Ceredig R (1990) Dissection of an inflammatory process induced by CD8+ T cells. Immunol Today 11: 55–59PubMedCrossRefGoogle Scholar
  13. Doymaz MZ, Rouse BT (1991) Herpetic stromal keratitis: an immunopathological disease mediated by CD4+ T lymphocytes (to be published)Google Scholar
  14. Doymaz MZ, Mercadal CM, Destephano D, Rouse BT (1991) MHC-II restricted, CD4+ cytotoxic T lymphocytes (CTL) specific for herpes simplex virus-1: implications for the development of herpetic stromal keratitis (HSK) in mice (to be published)Google Scholar
  15. Fiorentino DF, Bond BW, Mossmann TR (1989) Two types of mouse T helper cells. IV. T H2 clones secrete a factor that inhibits cytokine production by T HI cells. J Exp Med 170: 2081–2095PubMedCrossRefGoogle Scholar
  16. Foster CS, Tsai Y, Monroe JG, Campbell R, Cestari M, Wetzig R, Knipe D, Greene Ml (1986) Genetic studies on murine susceptibility to herpes simplex keratitis. Clin Immunol Immunopathol 40: 313–325PubMedCrossRefGoogle Scholar
  17. Fujinami RS (1989) Immune responses against myelin basic protein and/or galactocerebroside cross-react with viruses: implications for demyelinating disease. In: Oldstone MB (ed) Molecular mimicry. Cross-reactivity between microbes and host proteins as a cause of auto immunity. Springer, Berlin Heidelberg New York, pp 93–100 (Current topics in microbiology and immunology, vol 145)Google Scholar
  18. Hendricks RL, Tumpey T (1990) Contribution of virus and immune factors to herpes simplex virus type 1 induced corneal pathology. Invest Opthalmol Vis Sci 31:1929–1939Google Scholar
  19. Hendricks RL, Epstein RJ, Tumpey T (1989a) The effects of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis. Invest Opthalmol Vis Sci 30:105–115Google Scholar
  20. Hendricks RL, Tao MSP, Glorioso JC (1989b) Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis. J Immunol 142: 263–269PubMedGoogle Scholar
  21. Hollinger FB (1990) Hepatitis B virus. In: Fields BN, Knipe DM (eds) Virology, 2nd edn. Raven, New York, pp 2171–2224Google Scholar
  22. Hyndiuk RA, Glasser DB (1986) Herpes simplex keratitis. In: Tabbarra K, Hyndiuk RA (eds) Infections of the eye. Diagnosis and management. Little Brown, Boston, pp 343–368Google Scholar
  23. Ida S, Siragenian RP, Notkihs AL (1983) Cell bound and circulating IgE antibody to herpes simplex virus. J Gen Virol 64: 533–537PubMedCrossRefGoogle Scholar
  24. Igietseme JV, Calzada PJ, Gonzalez AR, Streilein, Atherton SS (1989) Protection of mice from herpes simplex virus-induced retinitis by in vitro activated immune cells. J Virol 63: 4808–4813PubMedGoogle Scholar
  25. Kaplan HJ, Streilein JW (1977) Immune response to immunization via the anterior chamber of the eye. I. F1 lymphocyte induced immune deviation. J Immunol 118:809–814PubMedGoogle Scholar
  26. Kaufman HE (1978) Herpetic keratitis. Invest Opthalmol Vis Sci 117: 941–957Google Scholar
  27. Klavinskis LS, Lindsay-Whitton J, Oldstone MBA (1989) Molecularly engineered vaccine which express an immunodominant T cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J Virol 63: 4311–4316PubMedGoogle Scholar
  28. Kolaitis G, Doymaz M, Rouse BT (1990) Demonstration of MHC class II restricted cytotoxic T lymphocytes in mice against herpes simplex virus. Immunology 71:101–106PubMedGoogle Scholar
  29. Ksander BR, Hendricks RL (1987) Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions. Invest Ophthalmol Vis Sci 28:1986–1992PubMedGoogle Scholar
  30. Liew FY (1987) Analysis of host protective and disease promoting T cells. Ann Inst Pasteur Immunol 138:749–755PubMedCrossRefGoogle Scholar
  31. Liew FY, Hale C, Howard JG (1985) Prophylactic immunization against experimental Leishmaniasis. IV subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection. J Immunol 135: 2095–2101PubMedGoogle Scholar
  32. Liew FY, Millott SM, Schmidt JA (1990) A repetitive peptide of leishmania can activate T helper type 2 cells and enhance disease progression. J Exp Med 172:1359–1365PubMedCrossRefGoogle Scholar
  33. Lipton HL (1975) Theiler’s virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun 11:1147–1155PubMedGoogle Scholar
  34. Massq PT, Dorries R, Ter Muelen V (1986) Viral particles induce la expression on astrocytes. Nature 320: 543–546CrossRefGoogle Scholar
  35. McBride BW, McGill Jl, Smith JL (1988) MHC-class-l and class-ll antigen expression in normal human corneas and in corneas from cases of herpetic keratitis. Immunology 65: 583–587PubMedGoogle Scholar
  36. Mehta PD, Kane A, Thormar H (1977) Quantitation of measles virus-specific immunoglobulins in serum, CSF and brain extract from patients with subacute sclerosing panencephalitis. J Immunol 118:2254–2261PubMedGoogle Scholar
  37. Metcalf JF (1984) Herpetic keratitis in normal and athymic mice. In: Tabbarra K, Cello RM (eds) Animal models of ocular diseases. Thomas, Spring field, pp 53–62Google Scholar
  38. Metcalf JF, Helmsen R (1977) Immunoelectron microscopic localization of herpes simplex virus antigens in rabbit cornea with anti-human IgG-antiferrin hybrid antibodies. Invest Ophthalmol Vis Sci 9: 779–786Google Scholar
  39. Metcalf JF, Kaufman HE (1976) Herpetic stromal keratitis: evidence for cell-mediated immunopatho-genesis. Am Ophthalmol 82: 827–837Google Scholar
  40. Metcalf JF, McNeil Jl, Kaufman HE (1976) Experimental disciform edema and necrotizing keratitis in rabbit. Invest Ophthalmol Vis Sci 12: 979–985Google Scholar
  41. Metcalf JF, Hamilton DS, Reichert RW (1979) Herpetic keratitis in athymic (nude) mice. Infect Immun 26: 1164–1171PubMedGoogle Scholar
  42. Meyers-Elliot RH, Chitjian PA (1981) Immunopathogenesis of corneal inflammation in herpes simplex virus stromal keratitis: role of the polymorphonuclear leucocytes. Invest Ophthalmol Vis Sci 20: 784–798Google Scholar
  43. Mims CA (1983) Immunopathology in virus diseases. Philos Trans R Soc Lond 308: 18–198Google Scholar
  44. Miyajima A, Miyataka S, Schreurs J, DeVries J, Arai N, Yokota T, Arai K (1988) Coordinate regulation of immune and inflammatory responses by T cell derived lymphokines. FASEB J 2: 2462–2473PubMedGoogle Scholar
  45. Mondelli MV, Chisari FV, Ferrari C (1990) The cellular immune response to nucleocapsid antigens in hepatitis virus infections. Springer Semin Immunopathol 12: 25–31PubMedCrossRefGoogle Scholar
  46. Morahan PS, Connor JR, Leary KR (1985) Viruses and versatile macrophage. Br Med Bull 41:15–21PubMedGoogle Scholar
  47. Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster Rl, Kanagawa O, Chisari FV (1990) Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248: 361–364PubMedCrossRefGoogle Scholar
  48. Mossmann TR, Coffman RL (1989) Heterogeneity and cytokine secretion patterns and functions of helper T cells. Adv Immunol 46:111–147CrossRefGoogle Scholar
  49. Nash AA, Gell PGH (1983) Membrane phenotype or murine effector and suppressor T cells involved in delayed type hypersensitivity and protective immunity to herpes simplex virus. Cell Immunol 75: 348–355PubMedCrossRefGoogle Scholar
  50. Nash AA, Gell PGH, Wildy P (1981) Tolerance and immunity in mice infected with herpes simplex virus. Simultaneous induction of protective immunity and tolerance to delayed-type hypersensiti-vity. Immunology 43:153–159PubMedGoogle Scholar
  51. Newell CK, Martin S, Sendele D, Mercadal CM, Rouse BT (1989a) Herpes simplex virus-induced stromal keratitis: role of T-lymphocytes subsets in immunopathology. J Virol 63: 769–775PubMedGoogle Scholar
  52. Newell CK, Sendele D, Rouse BT (1989b) Effects of CD4+ and CD8+ T lymphocyte depletion on the induction and expression of herpes simplex stromal keratitis. Regul Immunol 2: 366–369Google Scholar
  53. O’Brien WJ (1984) Herpetic eye diseases in animals as models for therapeutic studies of acute and latent herpesvirus infections. In: Rapp F, Herpesvirus. Liss, New York, pp 101–120Google Scholar
  54. O’Brien WJ (1986) Antiviral agents. In: Tabbarra K, Hyndiuk R (eds) Infections of the eye. Little Brown, Boston, pp 257–274Google Scholar
  55. Oh JO (1976) Primary and secondary herpes simplex uveitis in rabbits. Surv Ophthalmol 21:178–182PubMedCrossRefGoogle Scholar
  56. Oh JO, Minasi P, Grabner G, Ohashi Y (1985) Suppression of secondary herpes simplex uvetis by cyclosporine. Invest Ophthalmol Vis Sci 26: 494–500PubMedGoogle Scholar
  57. Oldstone MBA (1989) Moleculear mimicry as a mechanism for the cause and as a probe uncovering etiological agent(s) of autoimmune disease. In: Oldstone MB (ed) Molecular mimicry. Cross-reactivity between microbes and host proteins as a cause of autoimmunity. Springer, Berlin Heidelberg New York, pp 127–135 (Current topics in microbiology and immunology, Vol 145)Google Scholar
  58. Oldstone MBA, Tishon A, Buchmeier MJ (1983) Virus induced immune complex disease: genetic control of Clq binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus. J Immunol 130: 912–918PubMedGoogle Scholar
  59. Opremcak EM, Rice BA, Wells PA, Foster CS (1990) Histology and immunohistology of lgh-1 restricted herpes simplex keratitis in Balb/c congenic mice. Invest Ophthalmol Vis Sci 31: 305–312PubMedGoogle Scholar
  60. Oubina JR, Carballal G, Laguens RP, Quintans C, Merani S, Weisshenbacher MC (1988) Mortality induced by adoptive immunity in Junin virus-infected athymic mice Intervirology 29: 61–67PubMedGoogle Scholar
  61. Pircher H, Michalopoulos EE, Iwamato A, Ohashi PS, Beazinger J, Hengartner H, Zinkernagel RM, Mak T (1987) Molecular analysis of the antigen receptor of virus-specific cytotoxic T cells and identification of a new V-alpha family. Eur J Immunol 17:1843–1847PubMedCrossRefGoogle Scholar
  62. Plaut M (1990) Antigen specific lymphokine secretory patterns in atopic diseases. J Immunol 144: 4497–4500PubMedGoogle Scholar
  63. Rao NA, Atalla L, Linker-Israeli M, Chen FY, George IV FW, Martin WJ, Steinman L (1989) Suppression of experimental uveitis in rats by anti-IA antibodies. Invest Ophthalmol Vis Sci 30: 2348–2355PubMedGoogle Scholar
  64. Rickinson AB, Tao QY, Wallace LE (1985) The Epstein-Barr virus as a model of virus-host interactions. Br Med Bull 41: 75–79PubMedGoogle Scholar
  65. Rodriguez M, Sriram S (1988) Successful therapy of Theiler’s virus-induced demyelination (DA strain) with monoclonal anti-Ly 2 antibody. J Immunol 140: 2950–2955PubMedGoogle Scholar
  66. Rodriquez M, Pease LR, David CS (1986) Immune-mediated injury of virus-infected oligodendrocytes. Immunol Today 7: 359–363CrossRefGoogle Scholar
  67. Rouse BT (1985) Immunopathology of herpesvirus infections. In: Roizman B, Lopez C (eds) Herpesviruses, vol 4. Plenum, New York, pp 103–119Google Scholar
  68. Russell RG, Nasisse MP, Larsen HS, Rouse BT (1984) Role of T lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest Ophthalmol Vis Sci 25: 938–944PubMedGoogle Scholar
  69. Schmid DS (1988) The human MHC-II restricted cellular response to herpes simplex virus type-1 is mediated by CD4+ CD8+ T cells and is restricted to the DR region of MHC complex. J Immunol 140:3610–3616PubMedGoogle Scholar
  70. Sissons JGP, Borysiewiczs LK (1985) Viral immunopathology. Br Med Bull 41: 34–40PubMedGoogle Scholar
  71. Sorenson O, Percy D, Dales S (1980) In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats. Arch Neurol 37: 478–484Google Scholar
  72. Streilein JW (1987) Immune regulation and the eye: a dangerous compromise. FASEB J 1:199–208PubMedGoogle Scholar
  73. Stulting RD, Kindle JC, Nahmias AJ (1985) Patterns of herpes simplex keratitis in inbred mice. Invest Ophthalmol Vis Sci 26:1360–1367PubMedGoogle Scholar
  74. Ter Meulen V (1989) Virus-induced, cell-mediated autoimmunity. In: Notkins AL, Oldstone MBA (eds) Concepts in Viral pathogenesis III. Springer, Berlin Heidelberg New York, pp 297–303Google Scholar
  75. Watanabe R, Webe H, TerMeulen V (1983) Adoptive transfer of EAE-like lesions by MBP stimulated lymphocytes from rats with corona virus-induced demyelinating encephalomyelitis. Nature 305: 150–153PubMedCrossRefGoogle Scholar
  76. Welsh RJC, Tonks P, Nash AA, Blakemore WF (1987) Effects of L3T4T cell depletion on the pathogenesis of Theiler’s murine encephalomyelitis virus infection in CBA mice. J Gen Viral 68:1659–1667CrossRefGoogle Scholar
  77. Whitton J, Tishon A, Lewicki H, Gebhard J, Cook T, Salvato M, Joly E, Oldstone MBA (1989) Molecular analysis of a five amino acid cytotoxic T lymphocyte (CTL) epitope: an immunodominant region which induces non-reciprocal CTL crossreactivity. J Virol 63: 4303–4311PubMedGoogle Scholar
  78. Yanagi Y, Maekawa R, Cook T, Kanagawa O, Oldstone MBA (1990) Restricted V segment usage in T cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus. J Virol 64: 5919PubMedGoogle Scholar
  79. Yasukawa M, Inatsu A, Kobayashi Y (1988) Helper activity in antigen specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus. J Immunol 140: 3419–3425PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin, Heidelberg 1992

Authors and Affiliations

  • M. Z. Doymaz
    • 1
  • B. T. Rouse
    • 1
  1. 1.Department of MicrobiologyCollege of Veterinary Medicine University of TennesseeKnoxvilleUSA

Personalised recommendations